About
Nina Horowitz, PhD is the Chief Executive Officer of ImmuneBridge, a San Francisco cell-therapy company developing scalable cord-blood-derived immunotherapies. She trained at Stanford University and previously worked across research settings including Williams College, Mount Sinai, Boston University, and Stanford. Public sources in 2026 position her as a scientist-operator focused on cancer immunotherapy, NK cells, manufacturing, and age-associated disease applications rather than as an investor or fund manager.
Areas of interest
biotechcell therapyimmunotherapycancerstem cellscord bloodnatural killer cellsage-related diseaseslongevitymanufacturing scalabilityAI/ML for therapeutic screening